Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2023-03-20 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2023-03-20 English
Transaction in Own Shares 2023
Transaction in Own Shares Classification · 1% confidence The document is titled "Transactions in connection with share buy-back program" and details the number of shares bought back by the company between specific dates (March 13, 2023, to March 17, 2023) under an existing program. This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The filing type code POS (Transaction in Own Shares) is the most appropriate classification.
2023-03-20 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a detailed appendix listing individual share buyback transactions (volume, price, venue, and timestamp) for Genmab. This type of disclosure is a standard regulatory requirement for companies executing share repurchase programs. Since it reports the company's own share buyback activity, it falls under the 'Transaction in Own Shares' category.
2023-03-20 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, the total value, and the updated treasury share count. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2023-03-20 English
6-K
Foreign Filer Report
2023-03-13 English
Regulatory Filings 2023
Regulatory Filings Classification · 1% confidence The provided document text consists almost entirely of a structured table showing 'Volume', 'Price', 'Venue', and 'Time CET'. The content strongly resembles a log of trade executions or market data updates, likely sourced from a stock exchange (indicated by 'XCSE'). This format does not align with any of the defined comprehensive financial reports (10-K, IR, AR) or specific corporate actions (DIV, CAP, MANG). The codes listed in the table (e.g., 30, 29, 15, 16, 10, 5) appear to be internal transaction codes or security identifiers, not standard SEC/regulatory filing types. Since this is raw market data/activity log and does not fit any specific corporate disclosure category (like Earnings Release, Director's Dealing, or Capital Update), the most appropriate fallback category is 'Regulatory Filings' (RNS) for miscellaneous regulatory data feeds that don't fit elsewhere, although it is highly specialized market data.
2023-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.